SCHEMBL4883866

SCHEMBL4883866

CCC1(c2cccc([N+](=O)[O-])c2)C(C(=O)O)=C(C)N(C)C(C)=C1C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.43
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
TSHR P16473 2/20 0.39
ACHE P22303 1/20 0.39
MAPT P10636 1/20 0.39
PTBP1 P26599 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CHRNA1 P02708 1/20 0.39
CHRNG P07510 1/20 0.39
CHRNB1 P11230 1/20 0.39
CHRNB2 P17787 1/20 0.39
SLC6A2 P23975 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA4 P43681 1/20 0.39
SLC6A3 Q01959 1/20 0.39
CHRND Q07001 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9102109 0.85 TP53 (0.47) TP53L3MBTL1SMN1; SMN2TSHRACHE
SCHEMBL8827906 0.85 ALDH1A1 (0.39) TP53L3MBTL1SMN1; SMN2TSHRACHE
SCHEMBL7275212 0.84 SIGMAR1 (0.45) L3MBTL1SMN1; SMN2TSHRMAPTNPSR1
SCHEMBL10874214 0.84 TDP1 (0.38) TP53TDP1L3MBTL1SMN1; SMN2TSHR
SCHEMBL10567035 0.83 SIGMAR1 (0.43) TP53TDP1L3MBTL1SMN1; SMN2MAPT
SCHEMBL9249991 0.83 CACNA1B (0.45) L3MBTL1SMN1; SMN2MAPTALDH1A1ADORA3
SCHEMBL7326485 0.83 CACNA1B (0.45) L3MBTL1SMN1; SMN2MAPTALDH1A1ADORA3
SCHEMBL10872894 0.83 TDP1 (0.38) TP53TDP1L3MBTL1SMN1; SMN2TSHR
SCHEMBL7429615 0.82 TDP1 (0.37) TP53TDP1L3MBTL1SMN1; SMN2TSHR
SCHEMBL7365756 0.81 CACNA1B (0.40) TP53MAPTNPSR1ALDH1A1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-63041459-A None JP disclosed
US-20080095841-A1 Pharmaceutical Composition, Method for Producing the Same, and Method for Stabilizing Dihydropyridine Compound in the Pharmaceutical Composition EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-04-24 US disclosed
EP-1813274-A1 MEDICINAL COMPOSITION, PROCESS FOR PRODUCING THE SAME, AND METHOD OF STABILIZING DIHYDROPYRIDINE COMPOUND IN MEDICINAL COMPOSITION Eisai R&D Management Co., Ltd. (JP) 2007-08-01 EP disclosed
JP-S6341459-A PRODUCTION OF 2-(N-BENZYL-N-METHYLAMINO)- ETHYLMETHYL-2, 6-DIMETHYL-4-(M-NITROPHENYL)-1, 4-DIHYDROPYRIDINE-3, 5-DICARBOXYLATE AND HYDROCHLORIDE THEREOF LEK TOVARNA FARMACEVTSKIH 1988-02-22 JP disclosed